Isomorphic Labs · Series A
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Amount
$600M
Round
Series A
Valuation
—
Announced
—
Investors
Participating investors
Other Isomorphic Labs rounds
| Date | Round | Amount | |
|---|---|---|---|
| May 2026 | Series B | $2.1B | Details → |